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质向细胞核定向运输需要货物蛋白的核定位信号 NLS、识别并结合 NLS 的接头
蛋白细胞核输入蛋白 IMPα 及载体分子细胞核输入蛋白 IMPβ 三方的协调作用。
目前多种货物蛋白 NLSs 与细胞核输入蛋白 IMPα 的相互作用和结构生物学研究
极大的帮助了我们对核质蛋白转运机理的研究。 
细胞核输入蛋白 IMPα1，作为细胞核输入蛋白 IMPα 家族的一员，通常充当
通用入核载体而能与细胞内许多蛋白结合。赖氨酸乙酰转移酶 KAT8，是组蛋白
乙酰转移酶类 HATs 中 MYST 家族一员，参与了细胞众多最重要的生理与遗传过
程，包括基因转录调控、染色质组装、细胞周期调控、核仁结构的维持、DNA
损伤修复和细胞凋亡等。目前已经证明一部分功能是通过对 H4 K16 的乙酰化实
现的，另一部分则可能通过修饰其他的底物。研究证实 KAT8 的这些功能的发挥
都是在细胞核内进行的，不过它的合成却是在核外核糖体上完成的，因此弄清楚




核载体 IMPα1 间发生相互作用而揭示出赖氨酸乙酰转移酶 KAT8 可能借助核质
蛋白转运系统进行转运。随后我们纯化、结晶并解析出了 2.3Å 条件下
His-IMPα1(70-499) & IMPα1 (121-169)复合物的晶体结构。晶体结构显示 KAT8
以两段 NLS 多肽序列分别结合到了 IMPα1 上的主要结合位点 Major site 和次要
结合位点 Minor site 上。结合在次要结合位点 Minor site 上的 KAT8 NLS 采取了
类似于核内 RNA 解螺旋酶 Guα NLS 等的结构模式，即其 C 末端的氨基酸残基
















用力更强的 KAT8 NLS 与 IMPα1 上带相反电荷的氨基酸残基的离子键作用。在
细胞水平上的突变实验一方面揭示了 KAT8 NLS 上一些氨基酸残基对于介导
KAT8 与 IMPα1 的结合发挥了重要作用，在另一方面也验证了所得结构的合理
























As a notable characteristic of eukaryotic cells, the nuclear envelope separates the 
genetic materials and the transcriptional factory of the nucleus from the translation 
factory and the metabolic factory in the cytoplasm. This separation facilitates the 
regulation of many cellular physiological events, such as gene expression, signal 
transduction and cell cycle. The selective bidirectional transportation of some specific 
things is one of key aspects of this regulation. The nuclear import of macromolecular 
cargo-proteins needs the coordination of a nuclear location signal (NLS), an adaptor 
named importin α that can recognize and bind NLS, and the real carrier importin β. At 
present, many structural biological cases of the NLSs bound with importin α helps us 
greatly to understand the system and the mechanisms of nucleocytoplasmic transport. 
IMPα1 is a typical member of importin α and act as a usual adaptor that interacts 
with many proteins. Lysine acetyltransferase KAT8 is a histone acetyltransferase 
belonging to the MOZ, Ybf2/Sas3, Sas2 and Tip60 (MYST) family. KAT8 involves in 
many important physiological and genetic events of cells, such as regulation of 
transcription, chromatic organization, controlling of cell cycle, maintenance of 
nuclear structure, repairment of DNA damage and cell apotosis. It has been shown 
that one part of these functions of KAT8 was played by the acetylation of H4 K16, 
and the other maybe played by modifying other substrates. Now that these roles are 
worked in the nucleus, but its synthesis was carrying on ribosomes in the cytoplasma, 
it will be very useful for us to understand the mechanism of nuclear import. 
In this paper, by using co-immunopreciptation, we revealed that KAT8 interacts 
with the usual adaptor IMPα1 from the cellular and biochemical tests. Then we 
purified and solved the crystal structure of the protein complex of His-IMPα1 (70-499) 
& His-KAT8(121-169) at the resolution of 2.3Å. The crystal structure displays that 
KAT8 bound to the Major site and the Minor site of IMPα1 by two different NLSs. At 
the Minor site, KAT8 uses the same conformation as nuclear RNA helicase Guα bind 
















stabilize this α-helix, it uses the internal H-bond and more powerful ionic bond that 
from the charged atoms between KAT8 NLS and IMPα1. The site-directed 
mutagenesis experiments of KAT8 at the cellular level not only unveil the importance 
of several amino acid residues of KAT8 NLS in affecting the binding of KAT8 and 
IMPα1, but also verified the rationality of the structure model. The unique binding 
mode of KAT8 & IMPα1 will lead us to design some small molecular inhibitors that 
interfere the nuclear import of KAT8 with high specificity and selectivity. This study 
will also provide new ideal and potent drug targets for the target-based 
pharmaceutical design for controlling cell cycle, repairment of DNA damage and cell 
apoptosis.   
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种结构允许离子和分子量小于 40 kDa 的蛋白质分子以不耗能的方式自由扩散过
去，但限制性转运那些含有特定靶向信号的大分子，而且这些大分子的转运还需
要一些可溶性的转录因子或者载体分子的协助[6, 7]。 
    核转运途径主要受到小分子的鸟苷三磷酸酶家族（GTPase）Ran 蛋白的调控。
Ran 蛋白主要在 GDP 结合或 GTP 结合的状态间转换，而这两种状态的转换主要
是受到一些调控蛋白的调节，最重要的两种分别是 Ran 蛋白鸟苷酸交换因子（Ran 
guanine nucleotide exchange factor，RanGEF）或染色质凝缩调控因子 1（regulator 
of chromosome condensation 1，RCC1）和 Ran 蛋白鸟苷三磷酸酶激活蛋白（Ran 
GTPase-activating protein, RanGAP）[8, 9]。由于 RanGEF 主要位于细胞核内而
RanGAP 则位于细胞质内，这导致了结合不同核苷酸状态的 Ran 蛋白在核膜两侧
的不对称分布。而正是这种从细胞质到细胞核 RanGDP 至 RanGTP 的浓度梯度
指示了核质转运途径的方向。正常情况下，入核转运受体在细胞质一侧结合货物
分子，待进入核内结合 RanGTP 时释放货物；另一方面，出核转运受体在核内结
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